Global Biologics Drug Development Market Research Report 2024(Status and Outlook)
Report Overview
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
This report provides a deep insight into the global Biologics Drug Development market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Drug Development Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics Drug Development market in any manner.
Global Biologics Drug Development Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segmentation (by Type)
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segmentation (by Application)
In-House
Outsource
Pharma Excess
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Drug Development Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
This report provides a deep insight into the global Biologics Drug Development market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics Drug Development Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics Drug Development market in any manner.
Global Biologics Drug Development Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segmentation (by Type)
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segmentation (by Application)
In-House
Outsource
Pharma Excess
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologics Drug Development Market
- Overview of the regional outlook of the Biologics Drug Development Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics Drug Development Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biologics Drug Development
1.2 Key Market Segments
1.2.1 Biologics Drug Development Segment by Type
1.2.2 Biologics Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS DRUG DEVELOPMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics Drug Development Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics Drug Development Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS DRUG DEVELOPMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics Drug Development Sales by Manufacturers (2019-2024)
3.2 Global Biologics Drug Development Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics Drug Development Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics Drug Development Sales Sites, Area Served, Product Type
3.6 Biologics Drug Development Market Competitive Situation and Trends
3.6.1 Biologics Drug Development Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics Drug Development Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS DRUG DEVELOPMENT INDUSTRY CHAIN ANALYSIS
4.1 Biologics Drug Development Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS DRUG DEVELOPMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Drug Development Sales Market Share by Type (2019-2024)
6.3 Global Biologics Drug Development Market Size Market Share by Type (2019-2024)
6.4 Global Biologics Drug Development Price by Type (2019-2024)
7 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Drug Development Market Sales by Application (2019-2024)
7.3 Global Biologics Drug Development Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY REGION
8.1 Global Biologics Drug Development Sales by Region
8.1.1 Global Biologics Drug Development Sales by Region
8.1.2 Global Biologics Drug Development Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics Drug Development Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics Drug Development Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Drug Development Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics Drug Development Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Drug Development Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbvie
9.1.1 Abbvie Biologics Drug Development Basic Information
9.1.2 Abbvie Biologics Drug Development Product Overview
9.1.3 Abbvie Biologics Drug Development Product Market Performance
9.1.4 Abbvie Business Overview
9.1.5 Abbvie Biologics Drug Development SWOT Analysis
9.1.6 Abbvie Recent Developments
9.2 Allergan
9.2.1 Allergan Biologics Drug Development Basic Information
9.2.2 Allergan Biologics Drug Development Product Overview
9.2.3 Allergan Biologics Drug Development Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Biologics Drug Development SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Biologics Drug Development Basic Information
9.3.2 Boehringer Ingelheim Biologics Drug Development Product Overview
9.3.3 Boehringer Ingelheim Biologics Drug Development Product Market Performance
9.3.4 Boehringer Ingelheim Biologics Drug Development SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Biologics Drug Development Basic Information
9.4.2 Charles River Laboratories Biologics Drug Development Product Overview
9.4.3 Charles River Laboratories Biologics Drug Development Product Market Performance
9.4.4 Charles River Laboratories Business Overview
9.4.5 Charles River Laboratories Recent Developments
9.5 Catalent
9.5.1 Catalent Biologics Drug Development Basic Information
9.5.2 Catalent Biologics Drug Development Product Overview
9.5.3 Catalent Biologics Drug Development Product Market Performance
9.5.4 Catalent Business Overview
9.5.5 Catalent Recent Developments
9.6 Lonza Group
9.6.1 Lonza Group Biologics Drug Development Basic Information
9.6.2 Lonza Group Biologics Drug Development Product Overview
9.6.3 Lonza Group Biologics Drug Development Product Market Performance
9.6.4 Lonza Group Business Overview
9.6.5 Lonza Group Recent Developments
9.7 Amgen
9.7.1 Amgen Biologics Drug Development Basic Information
9.7.2 Amgen Biologics Drug Development Product Overview
9.7.3 Amgen Biologics Drug Development Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 Sanofi
9.8.1 Sanofi Biologics Drug Development Basic Information
9.8.2 Sanofi Biologics Drug Development Product Overview
9.8.3 Sanofi Biologics Drug Development Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
10 BIOLOGICS DRUG DEVELOPMENT MARKET FORECAST BY REGION
10.1 Global Biologics Drug Development Market Size Forecast
10.2 Global Biologics Drug Development Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics Drug Development Market Size Forecast by Country
10.2.3 Asia Pacific Biologics Drug Development Market Size Forecast by Region
10.2.4 South America Biologics Drug Development Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics Drug Development by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics Drug Development Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics Drug Development by Type (2025-2030)
11.1.2 Global Biologics Drug Development Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics Drug Development by Type (2025-2030)
11.2 Global Biologics Drug Development Market Forecast by Application (2025-2030)
11.2.1 Global Biologics Drug Development Sales (K Units) Forecast by Application
11.2.2 Global Biologics Drug Development Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biologics Drug Development
1.2 Key Market Segments
1.2.1 Biologics Drug Development Segment by Type
1.2.2 Biologics Drug Development Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS DRUG DEVELOPMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics Drug Development Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics Drug Development Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS DRUG DEVELOPMENT MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics Drug Development Sales by Manufacturers (2019-2024)
3.2 Global Biologics Drug Development Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics Drug Development Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics Drug Development Sales Sites, Area Served, Product Type
3.6 Biologics Drug Development Market Competitive Situation and Trends
3.6.1 Biologics Drug Development Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics Drug Development Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS DRUG DEVELOPMENT INDUSTRY CHAIN ANALYSIS
4.1 Biologics Drug Development Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS DRUG DEVELOPMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics Drug Development Sales Market Share by Type (2019-2024)
6.3 Global Biologics Drug Development Market Size Market Share by Type (2019-2024)
6.4 Global Biologics Drug Development Price by Type (2019-2024)
7 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics Drug Development Market Sales by Application (2019-2024)
7.3 Global Biologics Drug Development Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS DRUG DEVELOPMENT MARKET SEGMENTATION BY REGION
8.1 Global Biologics Drug Development Sales by Region
8.1.1 Global Biologics Drug Development Sales by Region
8.1.2 Global Biologics Drug Development Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics Drug Development Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics Drug Development Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics Drug Development Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics Drug Development Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics Drug Development Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Abbvie
9.1.1 Abbvie Biologics Drug Development Basic Information
9.1.2 Abbvie Biologics Drug Development Product Overview
9.1.3 Abbvie Biologics Drug Development Product Market Performance
9.1.4 Abbvie Business Overview
9.1.5 Abbvie Biologics Drug Development SWOT Analysis
9.1.6 Abbvie Recent Developments
9.2 Allergan
9.2.1 Allergan Biologics Drug Development Basic Information
9.2.2 Allergan Biologics Drug Development Product Overview
9.2.3 Allergan Biologics Drug Development Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Biologics Drug Development SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Biologics Drug Development Basic Information
9.3.2 Boehringer Ingelheim Biologics Drug Development Product Overview
9.3.3 Boehringer Ingelheim Biologics Drug Development Product Market Performance
9.3.4 Boehringer Ingelheim Biologics Drug Development SWOT Analysis
9.3.5 Boehringer Ingelheim Business Overview
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Biologics Drug Development Basic Information
9.4.2 Charles River Laboratories Biologics Drug Development Product Overview
9.4.3 Charles River Laboratories Biologics Drug Development Product Market Performance
9.4.4 Charles River Laboratories Business Overview
9.4.5 Charles River Laboratories Recent Developments
9.5 Catalent
9.5.1 Catalent Biologics Drug Development Basic Information
9.5.2 Catalent Biologics Drug Development Product Overview
9.5.3 Catalent Biologics Drug Development Product Market Performance
9.5.4 Catalent Business Overview
9.5.5 Catalent Recent Developments
9.6 Lonza Group
9.6.1 Lonza Group Biologics Drug Development Basic Information
9.6.2 Lonza Group Biologics Drug Development Product Overview
9.6.3 Lonza Group Biologics Drug Development Product Market Performance
9.6.4 Lonza Group Business Overview
9.6.5 Lonza Group Recent Developments
9.7 Amgen
9.7.1 Amgen Biologics Drug Development Basic Information
9.7.2 Amgen Biologics Drug Development Product Overview
9.7.3 Amgen Biologics Drug Development Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 Sanofi
9.8.1 Sanofi Biologics Drug Development Basic Information
9.8.2 Sanofi Biologics Drug Development Product Overview
9.8.3 Sanofi Biologics Drug Development Product Market Performance
9.8.4 Sanofi Business Overview
9.8.5 Sanofi Recent Developments
10 BIOLOGICS DRUG DEVELOPMENT MARKET FORECAST BY REGION
10.1 Global Biologics Drug Development Market Size Forecast
10.2 Global Biologics Drug Development Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics Drug Development Market Size Forecast by Country
10.2.3 Asia Pacific Biologics Drug Development Market Size Forecast by Region
10.2.4 South America Biologics Drug Development Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics Drug Development by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics Drug Development Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics Drug Development by Type (2025-2030)
11.1.2 Global Biologics Drug Development Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics Drug Development by Type (2025-2030)
11.2 Global Biologics Drug Development Market Forecast by Application (2025-2030)
11.2.1 Global Biologics Drug Development Sales (K Units) Forecast by Application
11.2.2 Global Biologics Drug Development Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Drug Development Market Size Comparison by Region (M USD)
Table 5. Global Biologics Drug Development Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biologics Drug Development Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics Drug Development Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics Drug Development Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2022)
Table 10. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics Drug Development Sales Sites and Area Served
Table 12. Manufacturers Biologics Drug Development Product Type
Table 13. Global Biologics Drug Development Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics Drug Development
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics Drug Development Market Challenges
Table 22. Global Biologics Drug Development Sales by Type (K Units)
Table 23. Global Biologics Drug Development Market Size by Type (M USD)
Table 24. Global Biologics Drug Development Sales (K Units) by Type (2019-2024)
Table 25. Global Biologics Drug Development Sales Market Share by Type (2019-2024)
Table 26. Global Biologics Drug Development Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics Drug Development Market Size Share by Type (2019-2024)
Table 28. Global Biologics Drug Development Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biologics Drug Development Sales (K Units) by Application
Table 30. Global Biologics Drug Development Market Size by Application
Table 31. Global Biologics Drug Development Sales by Application (2019-2024) & (K Units)
Table 32. Global Biologics Drug Development Sales Market Share by Application (2019-2024)
Table 33. Global Biologics Drug Development Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics Drug Development Market Share by Application (2019-2024)
Table 35. Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 37. Global Biologics Drug Development Sales Market Share by Region (2019-2024)
Table 38. North America Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 41. South America Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 43. Abbvie Biologics Drug Development Basic Information
Table 44. Abbvie Biologics Drug Development Product Overview
Table 45. Abbvie Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbvie Business Overview
Table 47. Abbvie Biologics Drug Development SWOT Analysis
Table 48. Abbvie Recent Developments
Table 49. Allergan Biologics Drug Development Basic Information
Table 50. Allergan Biologics Drug Development Product Overview
Table 51. Allergan Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Biologics Drug Development SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Boehringer Ingelheim Biologics Drug Development Basic Information
Table 56. Boehringer Ingelheim Biologics Drug Development Product Overview
Table 57. Boehringer Ingelheim Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim Biologics Drug Development SWOT Analysis
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Charles River Laboratories Biologics Drug Development Basic Information
Table 62. Charles River Laboratories Biologics Drug Development Product Overview
Table 63. Charles River Laboratories Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Recent Developments
Table 66. Catalent Biologics Drug Development Basic Information
Table 67. Catalent Biologics Drug Development Product Overview
Table 68. Catalent Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Catalent Business Overview
Table 70. Catalent Recent Developments
Table 71. Lonza Group Biologics Drug Development Basic Information
Table 72. Lonza Group Biologics Drug Development Product Overview
Table 73. Lonza Group Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Group Business Overview
Table 75. Lonza Group Recent Developments
Table 76. Amgen Biologics Drug Development Basic Information
Table 77. Amgen Biologics Drug Development Product Overview
Table 78. Amgen Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. Sanofi Biologics Drug Development Basic Information
Table 82. Sanofi Biologics Drug Development Product Overview
Table 83. Sanofi Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Global Biologics Drug Development Sales Forecast by Region (2025-2030) & (K Units)
Table 87. Global Biologics Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 89. North America Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 91. Europe Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Biologics Drug Development Sales Forecast by Region (2025-2030) & (K Units)
Table 93. Asia Pacific Biologics Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 95. South America Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Biologics Drug Development Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Biologics Drug Development Sales Forecast by Type (2025-2030) & (K Units)
Table 99. Global Biologics Drug Development Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Biologics Drug Development Price Forecast by Type (2025-2030) & (USD/Unit)
Table 101. Global Biologics Drug Development Sales (K Units) Forecast by Application (2025-2030)
Table 102. Global Biologics Drug Development Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics Drug Development Market Size Comparison by Region (M USD)
Table 5. Global Biologics Drug Development Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Biologics Drug Development Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics Drug Development Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics Drug Development Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics Drug Development as of 2022)
Table 10. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics Drug Development Sales Sites and Area Served
Table 12. Manufacturers Biologics Drug Development Product Type
Table 13. Global Biologics Drug Development Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics Drug Development
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics Drug Development Market Challenges
Table 22. Global Biologics Drug Development Sales by Type (K Units)
Table 23. Global Biologics Drug Development Market Size by Type (M USD)
Table 24. Global Biologics Drug Development Sales (K Units) by Type (2019-2024)
Table 25. Global Biologics Drug Development Sales Market Share by Type (2019-2024)
Table 26. Global Biologics Drug Development Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics Drug Development Market Size Share by Type (2019-2024)
Table 28. Global Biologics Drug Development Price (USD/Unit) by Type (2019-2024)
Table 29. Global Biologics Drug Development Sales (K Units) by Application
Table 30. Global Biologics Drug Development Market Size by Application
Table 31. Global Biologics Drug Development Sales by Application (2019-2024) & (K Units)
Table 32. Global Biologics Drug Development Sales Market Share by Application (2019-2024)
Table 33. Global Biologics Drug Development Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics Drug Development Market Share by Application (2019-2024)
Table 35. Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 37. Global Biologics Drug Development Sales Market Share by Region (2019-2024)
Table 38. North America Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 39. Europe Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 41. South America Biologics Drug Development Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Biologics Drug Development Sales by Region (2019-2024) & (K Units)
Table 43. Abbvie Biologics Drug Development Basic Information
Table 44. Abbvie Biologics Drug Development Product Overview
Table 45. Abbvie Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Abbvie Business Overview
Table 47. Abbvie Biologics Drug Development SWOT Analysis
Table 48. Abbvie Recent Developments
Table 49. Allergan Biologics Drug Development Basic Information
Table 50. Allergan Biologics Drug Development Product Overview
Table 51. Allergan Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Biologics Drug Development SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Boehringer Ingelheim Biologics Drug Development Basic Information
Table 56. Boehringer Ingelheim Biologics Drug Development Product Overview
Table 57. Boehringer Ingelheim Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Boehringer Ingelheim Biologics Drug Development SWOT Analysis
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Recent Developments
Table 61. Charles River Laboratories Biologics Drug Development Basic Information
Table 62. Charles River Laboratories Biologics Drug Development Product Overview
Table 63. Charles River Laboratories Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Charles River Laboratories Business Overview
Table 65. Charles River Laboratories Recent Developments
Table 66. Catalent Biologics Drug Development Basic Information
Table 67. Catalent Biologics Drug Development Product Overview
Table 68. Catalent Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Catalent Business Overview
Table 70. Catalent Recent Developments
Table 71. Lonza Group Biologics Drug Development Basic Information
Table 72. Lonza Group Biologics Drug Development Product Overview
Table 73. Lonza Group Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Group Business Overview
Table 75. Lonza Group Recent Developments
Table 76. Amgen Biologics Drug Development Basic Information
Table 77. Amgen Biologics Drug Development Product Overview
Table 78. Amgen Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. Sanofi Biologics Drug Development Basic Information
Table 82. Sanofi Biologics Drug Development Product Overview
Table 83. Sanofi Biologics Drug Development Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Sanofi Business Overview
Table 85. Sanofi Recent Developments
Table 86. Global Biologics Drug Development Sales Forecast by Region (2025-2030) & (K Units)
Table 87. Global Biologics Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 89. North America Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 91. Europe Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Biologics Drug Development Sales Forecast by Region (2025-2030) & (K Units)
Table 93. Asia Pacific Biologics Drug Development Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Biologics Drug Development Sales Forecast by Country (2025-2030) & (K Units)
Table 95. South America Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Biologics Drug Development Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Biologics Drug Development Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Biologics Drug Development Sales Forecast by Type (2025-2030) & (K Units)
Table 99. Global Biologics Drug Development Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Biologics Drug Development Price Forecast by Type (2025-2030) & (USD/Unit)
Table 101. Global Biologics Drug Development Sales (K Units) Forecast by Application (2025-2030)
Table 102. Global Biologics Drug Development Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biologics Drug Development
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Drug Development Market Size (M USD), 2019-2030
Figure 5. Global Biologics Drug Development Market Size (M USD) (2019-2030)
Figure 6. Global Biologics Drug Development Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Drug Development Market Size by Country (M USD)
Figure 11. Biologics Drug Development Sales Share by Manufacturers in 2023
Figure 12. Global Biologics Drug Development Revenue Share by Manufacturers in 2023
Figure 13. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics Drug Development Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics Drug Development Market Share by Type
Figure 18. Sales Market Share of Biologics Drug Development by Type (2019-2024)
Figure 19. Sales Market Share of Biologics Drug Development by Type in 2023
Figure 20. Market Size Share of Biologics Drug Development by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics Drug Development by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics Drug Development Market Share by Application
Figure 24. Global Biologics Drug Development Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics Drug Development Sales Market Share by Application in 2023
Figure 26. Global Biologics Drug Development Market Share by Application (2019-2024)
Figure 27. Global Biologics Drug Development Market Share by Application in 2023
Figure 28. Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics Drug Development Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biologics Drug Development Sales Market Share by Country in 2023
Figure 32. U.S. Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biologics Drug Development Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics Drug Development Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biologics Drug Development Sales Market Share by Country in 2023
Figure 37. Germany Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biologics Drug Development Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics Drug Development Sales Market Share by Region in 2023
Figure 44. China Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biologics Drug Development Sales and Growth Rate (K Units)
Figure 50. South America Biologics Drug Development Sales Market Share by Country in 2023
Figure 51. Brazil Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biologics Drug Development Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics Drug Development Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biologics Drug Development Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biologics Drug Development Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics Drug Development Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics Drug Development Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics Drug Development Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics Drug Development Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biologics Drug Development
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics Drug Development Market Size (M USD), 2019-2030
Figure 5. Global Biologics Drug Development Market Size (M USD) (2019-2030)
Figure 6. Global Biologics Drug Development Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics Drug Development Market Size by Country (M USD)
Figure 11. Biologics Drug Development Sales Share by Manufacturers in 2023
Figure 12. Global Biologics Drug Development Revenue Share by Manufacturers in 2023
Figure 13. Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics Drug Development Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics Drug Development Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics Drug Development Market Share by Type
Figure 18. Sales Market Share of Biologics Drug Development by Type (2019-2024)
Figure 19. Sales Market Share of Biologics Drug Development by Type in 2023
Figure 20. Market Size Share of Biologics Drug Development by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics Drug Development by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics Drug Development Market Share by Application
Figure 24. Global Biologics Drug Development Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics Drug Development Sales Market Share by Application in 2023
Figure 26. Global Biologics Drug Development Market Share by Application (2019-2024)
Figure 27. Global Biologics Drug Development Market Share by Application in 2023
Figure 28. Global Biologics Drug Development Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics Drug Development Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Biologics Drug Development Sales Market Share by Country in 2023
Figure 32. U.S. Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Biologics Drug Development Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics Drug Development Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Biologics Drug Development Sales Market Share by Country in 2023
Figure 37. Germany Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Biologics Drug Development Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Biologics Drug Development Sales Market Share by Region in 2023
Figure 44. China Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Biologics Drug Development Sales and Growth Rate (K Units)
Figure 50. South America Biologics Drug Development Sales Market Share by Country in 2023
Figure 51. Brazil Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Biologics Drug Development Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Biologics Drug Development Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Biologics Drug Development Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Biologics Drug Development Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Biologics Drug Development Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics Drug Development Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics Drug Development Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics Drug Development Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics Drug Development Market Share Forecast by Application (2025-2030)
